Effects of SM-20550 against myocardial infarction-induced arrhythmias, late infarct expansion, and left ventricular dysfunction

Journal of Cardiovascular Pharmacology

Volumn 50, Issue 5, 2007, Pages 563-570

  Grosjean, Noëlle ^a   Vié, Bruno ^a   Létienne, Robert ^a   Grand, Bruno Le ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Arrhythmias; Cariporide; Ischemia reperfusion; Left ventricle remodeling; SM 20550

Indexed keywords

CARIPORIDE; N AMIDINO 1,4 DIMETHYL 1H INDOLE 2 CARBOXAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; EXTRASYSTOLE; HEART ARRHYTHMIA; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE RELAXATION; HEART PROTECTION; HEART VENTRICLE REMODELING; HEART VENTRICLE TACHYCARDIA; HEART VENTRICLE WALL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE;

AMIDINES; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; BLOOD PRESSURE; CARDIOTONIC AGENTS; DOBUTAMINE; GUANIDINES; HEART; HEART RATE; INDOLES; MALE; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY; SULFONES; TACHYCARDIA, VENTRICULAR; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 36349008131     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e318149dfc9     Document Type: Article

References (44)

1. + exchange: structure, regulation, and its role in heart disease. Circ Res. 1999;85:777-786.
2. + exchange in ischemia-reperfusion. Bas Res Cardiol. 1996;91:191-202.
3. Scholz W, Albus U, Counillon L, et al. Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc Res. 1995;29:260-268.
4. + exchange. Cardiovasc Res. 1997;35:80-89.
5. +-exchange inhibition in regionally ischemic, reperfused porcine hearts. J Cardiovasc Pharmacol. 1997;30:235-240.
6. +-exchange inhibition in a regionally ischemic, reperfused porcine heart preparation with low residual blood flow. J Mol Cell Cardiol. 1998;30:795-801.
7. + exchange inhibitor, on ventricular arrhythmias in animal hearts. Eur J Pharmacol. 1996;317:309-316.
8. + exchange inhibitor, on accumulation of leukocytes in ischemia and reperfusion. Naunyn Schmiedeberg Arch Pharmacol. 2001;363:597-603.
9. + exchange inhibitor, in rabbits. Eur J Pharmacol. 2000;404:201-212.
10. + exchange inhibitor (SM 20550) protects from microvascular deterioration and myocardial injury after reperfusion. Eur J Pharmacol. 1999;374:355-366.
11. Bohle RM, Pich S, Klein HH. Modulation of the inflammatory response in experimental myocardial infarction. Eur Heart J. 1991;12:S28-S31.
12. 1- receptor induced late preconditioning and myocardial infarction: reperfusion duration is critical. Am J Physiol. 2002;283:H38-H43.
13. Pfeffer JM, Pfeffer MA, Fletcher PJ, et al. Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol. 1991;260:H1406-H1414.
14. + exchanger and cardiac hypertrophy. Circ Res. 1998;83:870-873.
15. Hayasaki-Kajiwara Y, Kitano Y, Iwasaki T, et al. Na(+) influx via Na(+)/H(+) exchange activates protein kinase C isozymes delta and epsilon in cultured neonatal rat cardiac myocytes. J Mol Cell Cardiol. 1999;31:1559-1572.
16. Chen L, Chen CX, Gan XT, et al. Inhibition and reversal of myocardial infarction-induced hypertrophy and heart failure by NHE-1 inhibition. Am J Physiol. 2004;286:H381-H387.
17. Karmazyn M, Sostaric JV, Gan XT. The myocardial Na+/H+ exchanger: a potential therapeutic target for the prevention of myocardial ischaemic and reperfusion injury and attenuation of postinfarction heart failure. Drugs. 2001;61:375-389.
18. + exchange inhibition reduces hypertrophy and heart failure after myocardial infarction in rats. Am J Physiol. 2001;280:H738-H745.
19. + exchange by cariporide reduces inflammation and heart failure in rabbits with myocardial infarction. Br J Pharmacol. 2004;142:1147-1154.
20. Walker MJ, Curtis MJ, Hearse DJ, et al. The lambeth conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc Res. 1988;22:447-455.
21. Sandmann S, Claas R, Cleutjens JP, et al. Calcium channel blockade limits cardiac remodeling and improves cardiac function in myocardial infarction-induced heart failure in rats. J Cardiovasc Pharm. 2001;37:64-77.
22. 2+- overload. J Cardiovasc Pharmacol. 2000;35:855-862.
23. + exchange inhibitor, on reperfusion ventricular arrhythmias in rat hearts. Eur J Pharmacol. 1997;339:121-127.
24. + exchanger attenuates phase 1b ischemic arrhythmias and reperfusion-induced ventricular fibrillation. Eur J Pharmacol. 2000;396:119-124.
25. Park CO, Xiao XH, Allen DG. Changes in intracellular Na+ and pH in rat heart during ischemia: role of Na+/H+ exchanger. Am J Physiol. 1999;276:H1581-H1590.
26. i during metabolic inhibition. Am J Physiol. 1995;268:H1239-H1248.
27. Van Borren MMGJ, Baartscheer A, Wilders R, et al. NHE-1 and NBC during pseudo-ischemia/reperfusion in rabbit ventricular myocytes. J Mol Cell Cardiol. 2004;37:567-577.
28. Lazdunski M, Frelin C, Vigne P. The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentration of sodium and internal pH. J Mol Cell Cardiol. 1985;17:1029-1042.
29. Avkiran M. Protection of the ischaemic myocardium by Na+/H+ exchange inhibitors: potential mechanisms of action. Basic Res Cardiol. 2001;96:306-311.
30. i load after ischemia and improves function in intact hearts. Am J Physiol. 2001;281:H2398-H2409.
31. Pike MM, Luo CS, Clark MD, et al. NMR measurements of Na+ and cellular energy in ischemic rat heart: role of Na+-H+ exchange. Am J Physiol. 1993;265:H2017-H2026.
32. Wajima T, Beguier B, Yaguchi M. Effects of cariporide (HOE642) on myocardial infarct size and ventricular arrhythmias in a rat ischemia/reperfusion model: comparison with other drugs. Pharmacology. 2004;70:68-73.
33. Weiss JL, Bulkley BH, Hutchins GM, et al. Two-dimensional echocardiographic recognition of myocardial injury in man: comparison with postmortem studies. Circulation. 1981;63:401-408.
34. Engelhardt S, Hein L, Keller U, et al. Inhibition of Na(+)-(H+) exchange prevents hypertrophy, fibrosis, and heart failure in beta(1)-adrenergic receptor transgenic mice. Circ Res. 2002;90:814-819.
35. Yokoyama H, Gunasegaram S, Harding SE, Avkiran M. Sarcolemmal Na+/H+ exchanger activity and expression in human ventricular myocardium. J Am Coll Cardiol. 2000;36:534-540.
36. Yokoyama H, Yasutake M, Avkiran M. Alpha1-adrenergic stimulation of sarcolemmal Na+-H+ exchanger activity in rat ventricular myocytes: evidence for selective mediation by the alpha1A-adrenoceptor subtype. Circ Res. 1998;82:1078-1085.
37. Kramer BK, Smith TW, Kelly RA. Endothelin and increased contractility in adult rat ventricular myocytes. Role of intracellular alkalosis induced by activation of the protein kinase C dependent Na(+)-H(+) exchanger. Circ Res. 1991;68:269-279.
38. Matsui H, Barry WH, Livsey C, et al. Angiotensin II stimulates sodiumhydrogen exchange in adult rabbit ventricular myocytes. Cardiovasc Res. 1995;29:215-221.
39. Yasutake M, Haworth RS, King A, et al. Thrombin activates the sarcolemmal Na(+)-H(+) exchanger. Evidence for a receptor mediated mechanism involving protein kinase C. Circ Res. 1996;79:705-715.
40. Yamazaki T, Komuro I, Kudoh S, et al. Role of ion channels and exchangers in mechanical stretch-induced cardiomyocyte hypertrophy. Circ Res. 1998;82:430-437.
41. Baartscheer A, Schumacher CA, van Borren MMGJ, et al. Chronic inhibition of Na+/H+ exchanger attenuates cardiac hypertrophy and prevents cellular remodeling in heart failure. Cardiovasc Res. 2005;65:83-92.
42. Theroux P, Chaitman BR, Danchin N, et al. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators. Circulation. 2000;102:3032-3038.
43. Mentzer RM Jr. Effects of Na+/H+ exchange inhibition by cariporide on death and nonfatal myocardial infarction in patients undergoing coronary artery bypass graft surgery: The EXPEDITION study. Circulation. 2003;108:3M.
44. Zeymer U, Suryapranata H, Monassier JP, et al. The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. J Am Coll Cardiol. 2001;38:1644-1650.